Aldeyra Therapeutics (ALDX) Posts Q1 Loss of $1.56/Share

Aldeyra Therapeutics (NASDAQ: ALDX) reported Q2 EPS of ($1.56), $1.03 worse than the analyst estimate of ($0.53).

For earnings history and earnings-related data on Aldeyra Therapeutics (ALDX) click here.

You May Also Be Interested In

• Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
• Lamb Weston (LW) Tops Q4 EPS by 25c; offers guidance
• Gentex Corporation (GNTX) Tops Q2 EPS by 8c ; Offers Guidance